Press Releases

Alan Michelson (2)_web.jpg

Dr. Alan Michelson to Advise LightIntegra Technology

June 26, 2018. LightIntegra Technology Inc., the creators of the ThromboLUX System, have announced that Dr. Alan Michelson has begun consulting as a Scientific Advisor.

Dr. Michelson is Professor of Pediatrics and Professor of Medicine at Harvard Medical School in Boston, Massachusetts, U.S.A. He is also the Director of the Center for Platelet Research Studies and Director of the Thrombosis and Anticoagulation Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.


Diagnostic Industry Veteran, Jim LaFrance, Joins the LightIntegra Technology Board of Directors

February 6, 2018. LightIntegra Technology Inc., creators of ThromboLUX, the first analyzer to provide a routine test for platelet activation status, announced today that Jim LaFrance has been appointed to its Board of Directors.

Jim LaFrance brings 30 years of experience in US diagnostic device commercialization to LightIntegra. Mr. LaFrance has extensive experience in various commercialization roles including Board Director, CEO, commercial general management, sales management, and strategic marketing.

LIT logo alone CMYK.png

LightIntegra Secures $3.5 Million Round of Financing

December 1, 2017. LightIntegra Technology. Inc. (LightIntegra) has secured $3.5 million in financing from its existing shareholder base. "This funding will help LightIntegra advance its commercialization efforts in the USA, and serves as a positive indication of the company's shareholder support," said Bill Dubiel, President and Chief Executive Officer. "The financing allows our company to generate working capital while maintaining its existing ownership structure."


LightIntegra Board Names Bill Dubiel as President & CEO

March 27, 2017. LightIntegra Technology Inc. today announced that its Board of Directors has appointed William "Bill" Dubiel as President and Chief Executive Officer effective March 13, 2017. Mr. Dubiel was also elected to the Board of Directors of LightIntegra. Paul Geyer will continue to serve as the Executive Chairman of LightIntegra.

"This is the perfect time for Bill to become LightIntegra's next President and Chief Executive Officer. We've selected a very strong leader at a time when LightIntegra is ready to take the leap to commercialize the ThromboLUX product," said LightIntegra's Executive Chairman and departing CEO Paul Geyer.